Loading...
Integrated population pharmacokinetics of etirinotecan pegol and its four metabolites in cancer patients with solid tumors
PURPOSE: Etirinotecan pegol (EP), a long-acting topoisomerase-1 inhibitor, is a polyethylene glycol conjugate of irinotecan, with an intended indication for treatment of breast cancer with brain metastases. The objective of this study was to develop a population pharmacokinetic (popPK) model of EP a...
Na minha lista:
| Udgivet i: | Cancer Chemother Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5907632/ https://ncbi.nlm.nih.gov/pubmed/29564497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-018-3562-3 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|